Quan Liao
- Cancer Research top 5%
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 31
- Cancer Cells and Metastasis 7
- Immunology top 5%
- Immune cells in cancer 13
- Phagocytosis and Immune Regulation 10
- Cell Biology top 5%
- Molecular Biology top 5%
-
- Pancreatitis Pathology and Treatment 9
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Cancer Research and Treatments 5
-
- Neuroendocrine Tumor Research Advances 5
- Co-authors
- Qiaofei LiuYupei ZhaoJörg KleeffRonghua ZhangMarkus W. BüchlerYalu ZhangMing CuiHelmut Friess
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- SHILAP Revista de lepidopterología (1 paper)Gastroenterology (1 paper)Annals of Surgery (2 papers)
- Partner nations
- ChinaGermanySwitzerland
In The Last Decade
Quan Liao
73 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 617
- Oncology 1.0k
- Immunology 583
- Cell Biology 317
- Molecular Biology 1.3k
Countries citing papers authored by Quan Liao
This map shows the geographic impact of Quan Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quan Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quan Liao more than expected).
Fields of papers citing papers by Quan Liao
This network shows the impact of papers produced by Quan Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quan Liao. The network helps show where Quan Liao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Quan Liao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 18 | |
| 4 | 2024 | 26 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 32 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 11 | |
| 10 | 2020 | 56 | |
| 11 | 2019 | 89 | |
| 12 | 2019 | 1 | |
| 13 | 2018 | 21 | |
| 14 | 2017 | 39 | |
| 15 | 2016 | 34 | |
| 16 | 2016 | 112 | |
| 17 | 2003 | 80 | |
| 18 | 2002 | 7 | |
| 19 | Heparanase expression in primary and metastatic pancreatic cancer. | 2001 | 216 |
| 20 | 2001 | 52 |
About Quan Liao
Quan Liao is a scholar working on Oncology, Immunology and Cancer Research, having authored 76 papers that have together received 2.5k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (31 papers), Immune cells in cancer (13 papers), Phagocytosis and Immune Regulation (10 papers), Pancreatitis Pathology and Treatment (9 papers), Cancer Cells and Metastasis (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cancer Research and Treatments (5 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Cancer Research (617 citations), Oncology (1.0k citations) and Immunology (583 citations). Quan Liao has collaborated with scholars based in China, Germany and Switzerland. Frequent co-authors include Qiaofei Liu, Yupei Zhao, Jörg Kleeff, Ronghua Zhang, Markus W. Büchler, Yalu Zhang, Ming Cui, Helmut Friess, Sen Yang and Arthur Zimmermann. Their work appears in journals such as SHILAP Revista de lepidopterología, Gastroenterology and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.